News

Drugs currently used to treat myeloproliferative disorders may help halt brain cancer before it becomes incurable. Read more

Heather Yeo, M.D., is a featured faculty member in the #WeAreWCM campaign. Read more

Meyer director Lewis Cantley will receive $4.2 million over 7 years to continue his research into PI3K and cancer metabolism. Read more

Feature about the use of virtual reality for cancer research at Weill Cornell Medicine. Read more

With the help of a 2016 Lori Milken–PCF Young Investigator Award from the Prostate Cancer Foundation, Loredana Puca, Ph.D., is studying the genomic characteristics of neuroendocrine prostate cancer and whether it might be possible to develop an epigenetic therapy to treat it. Read more

Lewis C. Cantley, Ph.D., and Kristy Richards, Ph.D., M.D. are collaborating to revamp the ways cancer drugs can be researched, tested and approved. Read more

Felice Schnoll-Sussman, M.D., appeared on the TODAY Show to review cancer screening guidelines by age Read more

An Ithaca-NYC team has found that the stiffening of the matrix surrounding a metastatic tumor plays a key role in the vascular makeup of the tumor that promotes tumor growth and mobility by keeping drugs out. Read more

Linda Vahdat, M.D., is turning to the public to help fund a trial for a new triple negative breast cancer treatment involving a simple oral medication that reduces copper levels in the patient’s body Read more